Metlife (MET) stock analysis and fair value
MET · NYSE · Life Insurance
100,96 US$
▲ +1,39%
Cerne score
62out of 100
Fair
- Quality88
- Growth41
- Valuation54
- Dividends72
In 30 seconds
The business. Life Insurance. Sells 77,1 B US$ a year, keeps 4% as profit and sales grow 2,6% a year (last 5 years).
Strength. Passes 4 of 5 quality checks and has more cash than debt.
MET fair value
Work out what the stock is worth with your own growth, margin and return assumptions. Free during launch.
See the fair valueMetlife key numbers
- Market cap
- 64,2 B US$
- P/E (price ÷ earnings)
- 21,4
- Dividend yield
- 2,23%
- Revenue growth
- 2,7%
- a year, over 9 years
- Profit margin
- 4,4%
- Quality checks
- 4/5
Fiscal 2025 financials, as filed with the SEC.
What analysts say
Buy
18 of 24 analysts recommend buying.
See everything about MET on Cerne
- Fair value with your own assumptions
- Every analyst and price target
- 10 years of financials in simple charts
- Dividends, earnings and ratios vs. the sector